Eikon Therapeutics, Inc. (EIKN)

Eikon Therapeutics, Inc. (EIKN) is a healthcare company (biotechnology) based in the United States. The share price is $5.15, down 4.36% on the day, which values the company at $279.06M. Price as of 17 Nov 2026, 21:32 UTC, from Yahoo Finance.

Key facts

Share price
$5.15−4.36% today
Market value
$279.06M
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Eikon Therapeutics, Inc. in more detail

EIKN trades at -0.8× next year's expected earnings.

In its favour: More cash than debt. Worth checking: Weak Piotroski score; Thin interest cover.

1 of the superinvestors tracked here hold EIKN, including Julian and Felix Baker (0.0% of the portfolio).

Superinvestors holding EIKN

1 of the investors tracked here report a position in their latest 13F filing.

Eikon Therapeutics, Inc. (EIKN): questions and answers

What is Eikon Therapeutics, Inc.'s market cap?

Eikon Therapeutics, Inc. is valued at $279.06M at a share price of $5.15.

Does EIKN pay a dividend?

Eikon Therapeutics, Inc. does not currently pay a regular dividend.

Which famous investors own EIKN?

In their latest quarterly filings, Julian and Felix Baker (0.0% of the portfolio) hold EIKN. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “Eikon Therapeutics, Inc. (EIKN) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/EIKN

Underlying data: Yahoo Finance; company filings with the SEC.